Anemia
Practitioners may not always adequately assess anemia in cancer patients
Published in Blood Weekly, May 29th, 2003
"Significant progress has been made in the prevention and management of many symptoms associated with cancer and its therapy," scientists in the United States report.
"Anemia in cancer may be secondary to blood loss, displacement of normal bone marrow cells by malignant cells, myelotoxic therapy, or the tumor itself. Practitioners may not always adequately assess anemia unless it represents a source of significant symptoms or patient distress," wrote T.W. Gillespie and colleagues, Emory University, School of Medicine.
"Risk factors include platinum-based...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2003-05-29)
More Articles from Blood Weekly
- Acute Myeloid Leukemia
Etiology may involve constitutional sequence variation in Fanconi anemia genes - Stem Cell Transplantation
T-cell depletion with Campath-1H 'in the bag' has multiple benefits - Allogeneic BMT
Pretreatment of donor with IL-18 attenuates acute GVHD, but preserves GVL effect - Hematopoiesis
Freshly dissociated fetal neural stem/progenitor cells don't turn into blood - Immunology
IL-15 + flt3-ligand or SCF induces differentiation of NKT cells from CB cells - Obstetrics
Anemia screening methods ineffective in pregnant women in Awassa, Ethiopia - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
